CD8A and neoplasm: In addition, the same group investigated the production of CD4+ CAR T cells in vivo using CD4-targeted LV, which showed a faster and superior tumor-eliminating capability compared with CD8-targeted LV in NSG mice reconstituted with human CD34+ cells, mainly because CD8+ T cells are more likely to be exhausted.83